Home LiteratureArticle Details
PMID: 186411 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.

Infection and immunity ·Vol. 14 ·No. 4 ·1976-10-00 ·Pages 982-9

Hamilton JR, Overall JC, Glasgow LA

Abstract

A synergistic effect on mortality was demonstrated in a combined infection of mice with murine cytomegalovirus (MCMV) and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans. Mice infected intraperitoneally with a 0 to 20% lethal dose inoculum of MCMV 3 days prior to the intravenous injection of a 0 to 20% lethal dose inoculum of either the bacteria or fungus demonstrated a striking enhancement of mortality. MCMV-infected mice given Pseudomonas or Staphylococcus exhibited a 90 to 100% mortality within 24 to 48 h, whereas 80% of viral-infected animals injected with Candida died in 5 days. Injection of the bacteria or fungus at various times during the MCMV infection resulted in enhanced mortality on days 0,1,2, and 3 of the viral infection. Greatest synergism was observed on day 3, with a progressive decline in death rates thereafter. Immunization with MCMV abrogated the synergistic effect on mortality in all three combined infections. Immunization with Pseudomonas reduced mortality in the combined MCMV-Pseudomonas infection. These results indicate that mice exhibit a markedly enhanced susceptibility to bacterial and fungal infections during the course of the MCMV infection and suggest that the enhancement may be related to viral-induced alterations in host resistance.

MeSH Terms
Animals Candida albicans/immunology Candidiasis/mortality Cytomegalovirus/immunology Cytomegalovirus Infections/mortality Dose-Response Relationship, Immunologic Female Immunization Mice Pseudomonas Infections/mortality Pseudomonas aeruginosa/immunology Staphylococcal Infections/mortality Staphylococcus aureus/immunology Time Factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Hamilton J R
Overall J C
Glasgow L A
References (37)
37 references, click to expand
  1. Enhancement of bacterial infections in mice by newcastle disease virus.
    Infect Immun. 1971 Mar;3(3):488-93 PMID: 16558000
  2. Role of macrophages in resistance to murine cytomegalovirus.
    Infect Immun. 1974 Dec;10(6):1383-90 PMID: 4140160
  3. Virus infections of the fetus and newborn infant.
    J Pediatr. 1970 Aug;77(2):315-33 PMID: 4194002
  4. The role of polymorphonuclear leucocytes in protecting mice vaccinated against Pseudomon as aeruginosa infections.
    Br J Exp Pathol. 1973 Aug;54(4):416-21 PMID: 4199239
  5. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis.
    Br Med J. 1965 Nov 6;2(5470):1099-102 PMID: 4284491
  6. Cytomegalovirus infection. Viral ultrastructure with particular reference to the relationship of lysosomes to cytoplasmic inclusions.
    Am J Pathol. 1966 Jun;48(6):971-89 PMID: 4287662
  7. Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice.
    Proc Soc Exp Biol Med. 1967 Feb;124(2):347-53 PMID: 4289713
  8. Immunosuppression during acute murine cytomegalovirus infection.
    J Immunol. 1968 Apr;100(4):835-44 PMID: 4296301
  9. Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza.
    J Infect Dis. 1968 Dec;118(5):449-62 PMID: 4302684
  10. Cytomegalovirus infection after renal transplantation. Report of a case with viremia and atypical lymphocytosis.
    JAMA. 1969 Mar 3;207(9):1712-4 PMID: 4304052
  11. Cytomegalovirus mononucleosis in previously healthy individuals. Five new cases and follow-up of 13 previously published cases.
    Ann Intern Med. 1969 Jul;71(1):11-9 PMID: 4307178
  12. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.
    N Engl J Med. 1971 Jul 22;285(4):203-14 PMID: 4325893
  13. Enzymatic and immunologic alterations in mice infected with lactic dehydrogenase virus.
    Am J Pathol. 1971 Sep;64(3):733-46 PMID: 4332293
  14. Cytomegalovirus syndrome following renal transplantation.
    Arch Surg. 1972 Oct;105(4):564-70 PMID: 4341907
  15. Thrombocytopenia in murine cytomegalovirus infection.
    J Lab Clin Med. 1973 Jan;81(1):53-63 PMID: 4344925
  16. Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases.
    Ann Intern Med. 1973 Aug;79(2):153-60 PMID: 4353663
  17. Cytomegalovirus infection in previously healthy adults.
    Ann Intern Med. 1973 Aug;79(2):267-8 PMID: 4353664
  18. The morphological consequences and the significance of cytomegalovirus infection in renal transplant patients.
    Q J Med. 1973 Jul;42(167):585-96 PMID: 4353832
  19. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine.
    J Infect Dis. 1973 Sep;128(3):290-9 PMID: 4353930
  20. Association of renal allograft rejection with virus infections.
    Am J Med. 1974 Mar;56(3):280-9 PMID: 4360465
  21. Impaired interferon response of children with congenital cytomegalovirus disease.
    Acta Paediatr Scand. 1974 Mar;63(2):183-7 PMID: 4362365
  22. Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant.
    J Infect Dis. 1974 May;129(5):511-8 PMID: 4362997
  23. Depression of human monocyte chemotaxis by herpes simplex and influenza viruses.
    J Immunol. 1974 Nov;113(5):1562-7 PMID: 4370991
  24. Cytomegalovirus-induced immune suppression. I. Humoral immunity.
    Clin Exp Immunol. 1974 Sep;18(1):109-18 PMID: 4377712
  25. Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity.
    Clin Exp Immunol. 1974 Sep;18(1):119-26 PMID: 4377713
  26. Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.
    Infect Immun. 1974 Jul;10(1):212-5 PMID: 4546284
  27. Inhibition of bactericidal capacity in mice after administration of Newcastle disease virus.
    Scand J Infect Dis. 1972;4(2):101-4 PMID: 4560874
  28. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.
    Infect Immun. 1972 May;5(5):775-82 PMID: 4629252
  29. Influenza and the interaction of viruses and bacteria in respiratory infections.
    Medicine (Baltimore). 1973 Sep;52(5):369-84 PMID: 4725960
  30. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.
    Infect Immun. 1971 Oct;4(4):462-7 PMID: 5005303
  31. Lactic dehydrogenase activity in blood.
    Proc Soc Exp Biol Med. 1955 Oct;90(1):210-3 PMID: 13273400
  32. Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids.
    Proc Soc Exp Biol Med. 1956 Jun;92(2):418-24 PMID: 13350367
  33. MOUSE CYTOMEGALOVIRUS INFECTION. AN ELECTRON MICROSCOPIC STUDY OF HEPATIC PARENCHYMAL CELLS.
    Am J Pathol. 1964 May;44:799-821 PMID: 14155026
  34. INCREASED SUSCEPTIBILITY OF MICE INFECTED WITH MOUSE ADENOVIRUS TO ESCHERICHIA COLI-INDUCED PYELONEPHRITIS.
    J Exp Med. 1964 Dec 1;120:1117-28 PMID: 14238929
  35. ACQUIRED CYTOMEGALOVIRUS INFECTION: ASSOCIATION WITH HEPATOMEGALY AND ABNORMAL LIVER-FUNCTION TESTS.
    N Engl J Med. 1965 Mar 25;272:602-9 PMID: 14255334
  36. THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.
    J Hyg (Lond). 1965 Mar;63:79-87 PMID: 14271930
  37. Virulence and attenuation of murine cytomegalovirus.
    Infect Immun. 1971 Feb;3(2):228-36 PMID: 16557958
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1976-10-00
Pages
982-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC415482
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]